Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Placental Protein Market by Product (Medical Grade, Cosmetic Grade, Others) and by Application (Skin Care Products, Drugs, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03403

Pages: NA

Charts: NA

Tables: NA

A placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange through the mother's blood supply. In addition, it aids in fighting against internal infection and produces hormones to support pregnancy.

This placenta is further hydrolyzed and is used for a variety of applications. The key factors that drive the global placental protein market are increase in incidence of skin infections and other associated diseases. However, prolonged use of placental protein may cause skin dryness, thus impeding the market growth. Moreover, introduction of placental protein products in untapped economies such as India, China, and Brazil is expected to create lucrative opportunities for key market players.

The global placental protein market is segmented based on product, application, and region. Based on product, it is divided into medical grade, cosmetic grade, and others. Based on application, it is classified into skin care products, drugs, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players, such as MED Skincare, Japan Bio Products Co., Ltd., CJT, Charites Japan, BIOON, Japan Natural Laboratories Co., Ltd., and Height Long Jiang Yinhe, are also provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging trends and dynamics in the global placental protein market.
  • In-depth analysis is done by constructing market estimations for the key market segments to identify the prevailing market opportunities.
  • This study evaluates the competitive landscape and value chain to understand the competitive environment across the geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Comprehensive analysis of all regions is provided to determine the prevailing opportunities in these geographies.

 Key Market Segments

  • By Product
    • Medical Grade
    • Cosmetic Grade
    • Others
  • By Application
    • Skin Care Products
    • Drugs
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • CJT
  • Japan Natural Laboratories Co., Ltd.
  • Charites Japan
  • Height Long Jiang Yinhe
  • MED Skincare
  • Abcam plc
  • BIOON
  • Takara Bio Inc
  • Japan Bio Products Co., Ltd.
  • VWR International

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: PLACENTAL PROTEIN MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Medical Grade

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Cosmetic Grade

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: PLACENTAL PROTEIN MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Skin Care Products

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Drugs

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: PLACENTAL PROTEIN MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Placental Protein Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Placental Protein Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Placental Protein Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Placental Protein Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Placental Protein Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Placental Protein Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Placental Protein Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Placental Protein Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Placental Protein Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Placental Protein Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Placental Protein Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Placental Protein Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Placental Protein Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Placental Protein Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Placental Protein Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Placental Protein Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Placental Protein Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Placental Protein Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Placental Protein Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Placental Protein Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Placental Protein Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Placental Protein Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Placental Protein Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Placental Protein Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Placental Protein Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. MED Skincare

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Japan Bio Products Co., Ltd.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. CJT

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Charites Japan

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. BIOON

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Japan Natural Laboratories Co., Ltd.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Height Long Jiang Yinhe

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. VWR International

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Takara Bio Inc

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Abcam Plc

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PLACENTAL PROTEIN MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL PLACENTAL PROTEIN MARKET FOR MEDICAL GRADE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL PLACENTAL PROTEIN MARKET FOR COSMETIC GRADE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL PLACENTAL PROTEIN MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL PLACENTAL PROTEIN MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL PLACENTAL PROTEIN MARKET FOR SKIN CARE PRODUCTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL PLACENTAL PROTEIN MARKET FOR DRUGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL PLACENTAL PROTEIN MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL PLACENTAL PROTEIN MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA PLACENTAL PROTEIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 13. U.S. PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 14. U.S. PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 15. CANADA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. CANADA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE PLACENTAL PROTEIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. ITALY PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. ITALY PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. UK PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. UK PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC PLACENTAL PROTEIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. CHINA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. CHINA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. INDIA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. INDIA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA PLACENTAL PROTEIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. UAE PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. UAE PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA PLACENTAL PROTEIN, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA PLACENTAL PROTEIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. MED SKINCARE: KEY EXECUTIVES
  • TABLE 73. MED SKINCARE: COMPANY SNAPSHOT
  • TABLE 74. MED SKINCARE: OPERATING SEGMENTS
  • TABLE 75. MED SKINCARE: PRODUCT PORTFOLIO
  • TABLE 76. MED SKINCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. JAPAN BIO PRODUCTS CO., LTD.: KEY EXECUTIVES
  • TABLE 78. JAPAN BIO PRODUCTS CO., LTD.: COMPANY SNAPSHOT
  • TABLE 79. JAPAN BIO PRODUCTS CO., LTD.: OPERATING SEGMENTS
  • TABLE 80. JAPAN BIO PRODUCTS CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 81. JAPAN BIO PRODUCTS CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. CJT: KEY EXECUTIVES
  • TABLE 83. CJT: COMPANY SNAPSHOT
  • TABLE 84. CJT: OPERATING SEGMENTS
  • TABLE 85. CJT: PRODUCT PORTFOLIO
  • TABLE 86. CJT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. CHARITES JAPAN: KEY EXECUTIVES
  • TABLE 88. CHARITES JAPAN: COMPANY SNAPSHOT
  • TABLE 89. CHARITES JAPAN: OPERATING SEGMENTS
  • TABLE 90. CHARITES JAPAN: PRODUCT PORTFOLIO
  • TABLE 91. CHARITES JAPAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. BIOON: KEY EXECUTIVES
  • TABLE 93. BIOON: COMPANY SNAPSHOT
  • TABLE 94. BIOON: OPERATING SEGMENTS
  • TABLE 95. BIOON: PRODUCT PORTFOLIO
  • TABLE 96. BIOON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. JAPAN NATURAL LABORATORIES CO., LTD.: KEY EXECUTIVES
  • TABLE 98. JAPAN NATURAL LABORATORIES CO., LTD.: COMPANY SNAPSHOT
  • TABLE 99. JAPAN NATURAL LABORATORIES CO., LTD.: OPERATING SEGMENTS
  • TABLE 100. JAPAN NATURAL LABORATORIES CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 101. JAPAN NATURAL LABORATORIES CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. HEIGHT LONG JIANG YINHE: KEY EXECUTIVES
  • TABLE 103. HEIGHT LONG JIANG YINHE: COMPANY SNAPSHOT
  • TABLE 104. HEIGHT LONG JIANG YINHE: OPERATING SEGMENTS
  • TABLE 105. HEIGHT LONG JIANG YINHE: PRODUCT PORTFOLIO
  • TABLE 106. HEIGHT LONG JIANG YINHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. VWR INTERNATIONAL: KEY EXECUTIVES
  • TABLE 108. VWR INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 109. VWR INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 110. VWR INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 111. VWR INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. TAKARA BIO INC: KEY EXECUTIVES
  • TABLE 113. TAKARA BIO INC: COMPANY SNAPSHOT
  • TABLE 114. TAKARA BIO INC: OPERATING SEGMENTS
  • TABLE 115. TAKARA BIO INC: PRODUCT PORTFOLIO
  • TABLE 116. TAKARA BIO INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ABCAM PLC: KEY EXECUTIVES
  • TABLE 118. ABCAM PLC: COMPANY SNAPSHOT
  • TABLE 119. ABCAM PLC: OPERATING SEGMENTS
  • TABLE 120. ABCAM PLC: PRODUCT PORTFOLIO
  • TABLE 121. ABCAM PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PLACENTAL PROTEIN MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PLACENTAL PROTEIN MARKET
  • FIGURE 3. SEGMENTATION PLACENTAL PROTEIN MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PLACENTAL PROTEIN MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPLACENTAL PROTEIN MARKET
  • FIGURE 11. PLACENTAL PROTEIN MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. PLACENTAL PROTEIN MARKET FOR MEDICAL GRADE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. PLACENTAL PROTEIN MARKET FOR COSMETIC GRADE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. PLACENTAL PROTEIN MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. PLACENTAL PROTEIN MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. PLACENTAL PROTEIN MARKET FOR SKIN CARE PRODUCTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. PLACENTAL PROTEIN MARKET FOR DRUGS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. PLACENTAL PROTEIN MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: PLACENTAL PROTEIN MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. MED SKINCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. MED SKINCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. MED SKINCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. JAPAN BIO PRODUCTS CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. JAPAN BIO PRODUCTS CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. JAPAN BIO PRODUCTS CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. CJT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. CJT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. CJT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. CHARITES JAPAN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. CHARITES JAPAN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. CHARITES JAPAN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. BIOON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. BIOON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. BIOON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. JAPAN NATURAL LABORATORIES CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. JAPAN NATURAL LABORATORIES CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. JAPAN NATURAL LABORATORIES CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. HEIGHT LONG JIANG YINHE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. HEIGHT LONG JIANG YINHE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. HEIGHT LONG JIANG YINHE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. VWR INTERNATIONAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. VWR INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. VWR INTERNATIONAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. TAKARA BIO INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. TAKARA BIO INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. TAKARA BIO INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. ABCAM PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. ABCAM PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. ABCAM PLC: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Placental Protein Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved